###begin article-title 0
###xml 63 69 <span type="species:ncbi:9913">bovine</span>
###xml 93 99 <span type="species:ncbi:9913">bovine</span>
The characterization of DNA methylation-mediated regulation of bovine placental lactogen and bovine prolactin-related protein-1 genes
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 129 134 129 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1</italic>
###xml 176 181 176 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1</italic>
###xml 184 190 184 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BCSH1 </italic>
###xml 194 200 194 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 486 492 486 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 496 502 496 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 772 778 772 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 782 788 782 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 0 6 <span type="species:ncbi:9913">Bovine</span>
###xml 84 90 <span type="species:ncbi:9913">bovine</span>
###xml 140 146 <span type="species:ncbi:9913">bovine</span>
###xml 378 384 <span type="species:ncbi:9913">cattle</span>
Bovine trophoblast binucleate cells (BNC) express a plethora of molecules including bovine placental lactogen (bPL, gene name is bCSH1) and bovine prolactin-related protein-1 (bPRP1). BCSH1 and bPRP1 are members of the growth hormone (GH)/prolactin (PRL) gene family, which are expressed simultaneously in BNC and are central to placentation and the progression of pregnancy in cattle. However, there is a paucity of information on the transcriptional regulatory mechanisms of both the bCSH1 and bPRP1 genes. Recent studies, however, have demonstrated that the expression of a number of genes is controlled by the methylation status of their promoter region. In the present study, we examined the cell-type-specific epigenetic alterations of the 5'-flanking region of the bCSH1 and bPRP1 genes to gain an insight into their regulatory mechanisms.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 63 69 63 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 201 207 201 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 392 398 392 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 452 458 452 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 570 576 570 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 638 644 638 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 782 788 782 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 796 801 796 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1</italic>
###xml 500 506 <span type="species:ncbi:9913">bovine</span>
###xml 605 611 <span type="species:ncbi:9913">bovine</span>
Analysis of 5-aza-2'-deoxycytidine treatment demonstrated that bCSH1 expression is moderately induced in fibroblast cultures but enhanced in BT-1 cells. Sodium bisulfite based sequencing revealed that bCSH1 is hypomethylated in the cotyledonary tissue but not in the fetal skin, and this pattern was not altered with the progression of pregnancy. On the other hand, the methylation status of bPRP1 was similar between the cotyledon and fetal skin. The bPRP1 gene was exclusively hypermethylated in a bovine trophoblast cell-derived BT-1 cell-line. While the activity of bCSH1 was similar in both BT-1 and bovine fibroblast cells, that of bPRP1 was specific to BT-1. Treatment with a demethylating agent and luciferase assays provided in vitro evidence of the positive regulation of bCSH1 but not bPRP1.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 83 89 83 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 93 99 93 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 124 130 124 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 334 340 334 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 344 350 344 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 476 482 <span type="species:ncbi:9913">bovine</span>
This is the first report to identify the differential regulatory mechanisms of the bCSH1 and bPRP1 genes and indicates that bCSH1 might potentially be the only transcript that is subject to DNA methyltransferase regulation. The data indicates the possibility of novel kinetics of induction of the synchronously expressed BNC-specific bCSH1 and bPRP1 transcripts, which may aid the understanding of the intricate regulation and specific role(s) of these important molecules in bovine placentogenesis and the progression of pregnancy.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1</italic>
###xml 160 161 160 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 162 163 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 187 193 187 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 197 203 197 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 251 252 251 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 328 329 328 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 452 453 452 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 454 455 454 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 458 464 458 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BCSH1 </italic>
###xml 529 530 529 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 531 532 531 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 644 645 644 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 646 647 646 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 648 649 648 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 650 652 650 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 653 655 653 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 684 690 684 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 694 700 694 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 767 769 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 770 772 770 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1008 1014 1008 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 1057 1059 1057 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1060 1062 1060 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1179 1185 1179 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 1243 1249 1243 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 1364 1366 1364 1366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1367 1369 1367 1369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1765 1767 1765 1767 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PL</italic>
###xml 1775 1780 1775 1780 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PL-I </italic>
###xml 1863 1869 1863 1869 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PL-II </italic>
###xml 1931 1934 1931 1934 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PL </italic>
###xml 1982 1984 1982 1984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1985 1987 1985 1987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 2130 2132 2130 2132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 2133 2135 2133 2135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 2249 2251 2249 2251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 2450 2452 2450 2452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 2453 2455 2453 2455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 2616 2618 2616 2618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 2619 2621 2619 2621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 2685 2691 2685 2691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 2695 2701 2695 2701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 2826 2832 2826 2832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 2836 2841 2836 2841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1</italic>
###xml 0 6 <span type="species:ncbi:9913">Bovine</span>
###xml 54 60 <span type="species:ncbi:9913">bovine</span>
###xml 255 261 <span type="species:ncbi:9913">Bovine</span>
###xml 521 527 <span type="species:ncbi:9606">humans</span>
###xml 617 623 <span type="species:ncbi:9913">cattle</span>
###xml 625 630 <span type="species:ncbi:9925">goats</span>
###xml 636 641 <span type="species:ncbi:9940">sheep</span>
###xml 1565 1572 <span type="species:ncbi:9913">bovines</span>
###xml 1759 1764 <span type="species:ncbi:9606">human</span>
###xml 1769 1774 <span type="species:ncbi:10090">mouse</span>
###xml 1859 1862 <span type="species:ncbi:10116">rat</span>
###xml 2233 2239 <span type="species:ncbi:9913">bovine</span>
Bovine placental lactogen (bPL, gene name: bCSH1) and bovine prolactin-related protein 1 (bPRP1) are members of the growth hormone (GH)/prolactin (PRL) family [1,2]. The homology between bCSH1 and bPRP1 is 62% for nucleotides and 36% for amino acids [1]. Bovine PL is classified as a classical member of the GH/PRL gene family [3]. In contrast, thirteen isoforms of bPRP have been identified and are categorized as nonclassical members of this family [4-7]. BCSH1 has been detected in various mammalian species including humans [1,8-13], while orthologues of PRP1 have been detected in several animals (e.g., rodent, cattle, goats, and sheep) [2,4-7,14-16]. In the ruminant placenta, bCSH1 and bPRP1 are concurrently detected in trophoblastic binucleate cells (BNC) [17,18]. The expression of both transcripts becomes apparent in BNC from about day 20 of gestation. Coincidentally, the earliest detection of the transcripts parallels the appearance of BNC in the fetal trophoblast, and studies indicate that bCSH1 is a reliable marker of BNC morphogenesis [17,18]. However, the temporal profile of these two genes are disparate during gestation such that the expression level of bCSH1 increases with the progression of pregnancy; whereas, the bPRP1 expression pattern is biphasic with a gradual increase up to mid-gestation followed by a period of steady decline [19,20]. Despite advances in the unraveling of GH/PRL gene sequences, structural characteristics, expression sites, and cell localization, little is known about their molecular regulatory mechanisms in bovines. Recent studies have revealed the transcriptional regulatory factors of the PL-family in other species; for example, Sp1 has been identified as an important factor for the expression of human PL; mouse PL-I has been shown to be activated by activator protein (AP) -1, GATA2, and GATA3; rat PL-II is reported to have binding sites for Ets and AP-1; and ovine PL is documented to be activated by AP-2 and GATA [21-25]. However, there is limited information on the factors that regulate the expression of the PRP gene, particularly in the artiodactyl species [15,16]. Recently, we reported that the AP-2 family may be involved in the regulation of these genes in bovine species [26], although additional studies are necessary to confirm this finding. However, a growing body of evidence suggests that mechanisms involving epigenetic changes regulate the expression of some genes [27-34]. Epigenetic modification involving DNA methylation has been demonstrated to be central to tissue-dependent gene expression, embryogenesis, and carcinogenesis [27-34]. We hypothesized that the differential expression patterns of bCSH1 and bPRP1 are controlled by DNA methylation, and in this study we investigated whether DNA methylation regulates the expression of the bCSH1 and bPRP1genes in trophoblast cells.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
###xml 27 33 27 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 37 43 37 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
The effects of 5-aza-dC on bCSH1 and bPRP1 expression in cultured cells
###end title 11
###begin p 12
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 248 253 248 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1</italic>
###xml 255 261 255 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 308 314 308 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
The bCSH1 expression was moderately induced in 5-aza-dC-supplemented fibroblast cultures (P < 0.05); whereas, there was an increase in the overall expression intensity in BT-1 5-aza-dC treated cultures (P < 0.05) (Figure 1A and 1B). In contrast to bCSH1, bPRP1 expression was decreased in BT-1 cells, but no bPRP1 expression was detected in fibroblasts (Figure 1C and 1D).
###end p 12
###begin p 13
###xml 0 64 0 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The effects of 5-aza-dC on BT-1 and endometrial fibroblast cells</bold>
###xml 91 97 91 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 108 114 108 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 331 337 330 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH </italic>
###xml 387 389 386 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-3</sup>
###xml 445 448 444 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-5 </sup>
The effects of 5-aza-dC on BT-1 and endometrial fibroblast cells. The expression levels of bCSH1 (A, B) and bPRP1 (C, D) mRNA were determined by quantitative real-time RT-PCR. Ten muM of 5-aza-dC were added to both cell populations (A, C: BT-1; B, D: endometrial fibroblast cells). The expression levels were normalized to that of GAPDH mRNA. All results are displayed on a y-scale of 10-3, except for the insert in (B) where it is reduced to 10-5 to depict the low expression levels. Values are shown as the mean +/- SEM, and values marked with an asterisk are significantly different (*P < 0.05).
###end p 13
###begin title 14
###xml 56 62 56 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1</italic>
Determination of CpG sites in the 5'-flanking region of bCSH1 and bPRP1
###end title 14
###begin p 15
###xml 43 49 43 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 130 135 130 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1</italic>
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 210 216 210 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BPRP1 </italic>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
The CpG sites in the 5'-flanking region of bCSH1 and bPRP1 were examined using Day 150 COT. In all, 19 CpG sites were detected in bCSH1, from -4090 to the transcription starting site, as is shown in Figure 2A. BPRP1 had 9 CpG sites from -860 to the transcription starting site, as is shown in Figure 3A.
###end p 15
###begin p 16
###xml 57 63 57 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 0 101 0 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The detection of CpG sites and the methylation status of <italic>bCSH1 </italic>in placentomes on day 150 of gestation</bold>
###xml 140 146 140 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
The detection of CpG sites and the methylation status of bCSH1 in placentomes on day 150 of gestation. (A) The location of CpG sites in the bCSH1 5'-flanking region. (B) The DNA methylation ratio of Day 150 COT (n = 3, 10 clones for each sample) and Day 150 SKIN samples (n = 2, 15 clones for each sample). The black bars indicate SKIN and the white bars depict COT samples. Values show the percentage total from 30 clones, and values marked with an asterisk(s) are significantly different (*P < 0.05).
###end p 16
###begin p 17
###xml 57 63 57 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 0 101 0 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The detection of CpG sites and the methylation status of <italic>bPRP1 </italic>in placentomes on day 150 of gestation</bold>
###xml 140 146 140 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
The detection of CpG sites and the methylation status of bPRP1 in placentomes on day 150 of gestation. (A) The location of CpG sites in the bCSH1 5'-flanking region. (B) The DNA methylation ratio of Day 150 COT (n = 3, 10 clones for each sample) and Day 150 SKIN samples (n = 2, 15 clones for each sample). The black bars indicate SKIN and the white bars depict COT samples. Values show the percentage total from 30 clones, and values marked with an asterisk(s) are significantly different (*P < 0.05).
###end p 17
###begin title 18
The DNA methylation statuses of cotyledon and fetal skin
###end title 18
###begin p 19
###xml 114 120 114 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 124 130 124 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
Using samples from Day 150 COT and fetal skin (SKIN), the DNA methylation status of the 5'-flanking region of the bCSH1 and bPRP1 genes was examined using bisulfate sequencing.
###end p 19
###begin title 20
bCSH1
###end title 20
###begin p 21
###xml 37 43 37 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 531 533 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
We divided the 5'-flanking region of bCSH1 into 6 regions (region 1: -354 to -147 bp; region 2: -992 to -541 bp; region 3: -2099 to -1651 bp; region 4: -2711 to -2300 bp; region 5: -3428 to -3103 bp; region 6: -4094 to -3742 bp) depending on the distribution of the CpG sites. DNA was hypomethylated in the COT but not in the SKIN samples. In all, 14 CpG sites (among -3343 to -215 bp) showed a significantly low methylation status (P < 0.05). Seven of these 14 CpG sites were assumed to be located between regions 1 and 2 (Figure 2B).
###end p 21
###begin title 22
bPRP1
###end title 22
###begin p 23
###xml 37 43 37 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
We divided the 5'-flanking region of bPRP1 into 2 regions (region 1: -495 to -75 bp; region 2: -963 to -535 bp). The DNA methylation status was similar between the COT and SKIN samples. Only 3 CpG sites (-470, -269 and -197 bp) in region 1 had a significantly low-level of methylation (P < 0.05) (Figure 3B).
###end p 23
###begin title 24
###xml 23 29 23 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 33 39 33 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
Dynamic changes in the bCSH1 and bPRP1 gene methylation levels in cotyledonary tissue during gestation
###end title 24
###begin title 25
bCSH1
###end title 25
###begin p 26
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 246 247 246 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
We selected 7 CpG sites in regions 1 and 2 to compare their methylation status during gestation (Figure 4A) based on our findings of the CpG sites that exhibited significantly low methylation levels in the day 150 COT samples, as shown in Figure 2.
###end p 26
###begin p 27
###xml 34 40 34 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 44 50 44 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 0 64 0 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The dynamic methylation status of <italic>bCSH1 </italic>and <italic>bPRP1 </italic>in placentomes</bold>
###xml 121 126 121 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1</italic>
###xml 276 281 276 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1</italic>
The dynamic methylation status of bCSH1 and bPRP1 in placentomes. (A) The dynamic DNA methylation ratios at each site in bCSH1. The black bar indicates Day 90 COT, the gray bar Day 150 COT, and the white bar Day 250 COT. (B) The dynamic DNA methylation ratios at each site in bPRP1. The black bar indicates Day 60 COT, the gray bar Day 150 COT, and the white bar Day 250 COT. Values show the percentage total from 30 clones (n = 3, 10 clones for each sample), and values marked with an asterisk(s) are significantly different (*P < 0.05).
###end p 27
###begin p 28
On day 90 of gestation, the methylation ratios at two CpG sites (-580 and -280) were lower (33.3%) in comparison to the other sites (53.3% to 73.3%). These lower ratios were maintained at the above loci throughout gestation. However, no results were significantly different (P > 0.05).
###end p 28
###begin title 29
bPRP1
###end title 29
###begin p 30
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
We examined a total of 9 CpG sites in regions 1 and 2 during gestation (Figure 4B). On day 60 of gestation, 7 out of the 9 sites showed a relatively low methylation ratio (< 50%). In particular, two CpG sites (-839 and -708) showed extremely low methylation ratios, and the observed ratio was maintained up to day 250 of gestation at these sites. The methylation levels increased at sites -820 and -813 by day 150, and the hypermethylation status was maintained up to day 250 at these sites. The methylation ratios at sites -326 and -197 decreased to half the values observed on day 60. One specific site, -197, exhibited a very low methylation ratio (only 10%) on day 250 of gestation (P < 0.05). A steady pattern of hypomethylation was observed at CpG sites -839, -780, and -708 throughout gestation.
###end p 30
###begin title 31
###xml 30 36 30 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 40 46 40 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
The DNA methylation status of bCSH1 and bPRP1 in BT-1
###end title 31
###begin title 32
bCSH1
###end title 32
###begin p 33
###xml 19 25 19 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 223 229 <span type="species:ncbi:9913">bovine</span>
Seven CpG sites in bCSH1 regions 1 and 2 were analyzed by sodium bisulfate sequencing using BT-1 genomic DNA. A lower (P < 0.05) methylation ratio was found at the -580 site in BT-1 cells compared to the levels detected in bovine fibroblast cells (Figure 5A).
###end p 33
###begin p 34
###xml 30 36 30 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 40 46 40 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 0 59 0 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The DNA methylation status of <italic>bCSH1 </italic>and <italic>bPRP1 </italic>in BT-1 cells</bold>
###xml 137 143 137 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 151 156 151 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1</italic>
The DNA methylation status of bCSH1 and bPRP1 in BT-1 cells. The DNA methylation ratios of BT-1 and cotyledonary fibroblast cells in (A) bCSH1 and (B) bPRP1. The black bar indicates cotyledonary fibroblast cells, and the white bar depicts BT-1 cells. The values show the percentage total from 30 clones, and values marked with an asterisk(s) are significantly different (*P < 0.05).
###end p 34
###begin title 35
bPRP1
###end title 35
###begin p 36
###xml 18 24 18 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
Nine CpG sites in bPRP1 regions 1 and 2 were analyzed by sodium bisulfate sequencing using BT-1 genomic DNA. Seven of the 9 CpG sites were hypermethylated in the BT-1 cells (more than 50%), and six out of the 9 sites were hypermethylated in the fibroblasts. The -708, -470, and -269 sites showed a higher (P < 0.05) methylation ratio in the BT-1 cells than in the fibroblasts. Whereas, the methylation rate at the CpG -326 site was lower (P < 0.05) in the BT-1 cells (Figure 5B).
###end p 36
###begin title 37
###xml 62 68 62 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
The transcriptional activity in the 5'-flanking region of the bCSH1 and bPRP1 genes
###end title 37
###begin title 38
bCSH1
###end title 38
###begin p 39
###xml 9 15 9 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 655 657 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 662 664 662 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
The -213 bCSH1 Luc construct had the highest transcriptional activity in the BT-1 (8.4 fold to the control) cells. The -368 and -599 Luc constructs had 4.1 and 7.3 fold higher activity relative to the no-promoter controls, respectively. A reduction in promoter activity was noted for the methylated -368 (P < 0.05) and -599 constructs in the BT-1 cells. The transcriptional activity of these constructs in fibroblasts was comparable: the -213, -368, and -599 constructs showed 11.8 (P < 0.05), 7.9, and 4.7 fold activity, respectively. In contrast, methylation of the -368 (P < 0.05) and -599 constructs dramatically reduced the promoter activity (Figure 6A and 6B) in the fibroblasts.
###end p 39
###begin p 40
###xml 32 38 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 42 48 42 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 0 88 0 88 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The transcriptional activity of <italic>bCSH1 </italic>and <italic>bPRP1 </italic>constructs in BT-1 cells and fibroblasts</bold>
###xml 201 206 201 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1</italic>
###xml 239 244 239 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1</italic>
###xml 144 150 <span type="species:ncbi:9913">bovine</span>
The transcriptional activity of bCSH1 and bPRP1 constructs in BT-1 cells and fibroblasts. The transcriptional activity of BT-1 cells (A, C) and bovine fibroblast cells (B, D). (A) and (B) show that of bCSH1, while (C) and (D) show that of bPRP1. The left figures show constructs, the horizontal lines indicate the length of the constructs, and the circles indicate the CpG sites. "M" and the black circles indicate methylated constructs, and "U" and white circles indicate unmethylated constructs. The values are shown as the mean +/- SEM (n = 3), and values marked with an asterisk(s) are significantly different (*P < 0.05).
###end p 40
###begin title 41
bPRP1
###end title 41
###begin p 42
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
###xml 568 570 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D</xref>
The first two fragments of the 5'-flanking region (-50 and -80) demonstrated no transcriptional activity, in BT-1 or fibroblast cells. The highest activity in the BT-1 cells was found with the -277 Luc construct (13.9 fold, P < 0.05), and increased activity was also found in the -510 (5.3 fold) and -860 (3.7 fold) constructs. Whereas, in the fibroblasts, only the -510 construct had a higher transcriptional activity than the control. Three methylated constructs from -277 to -860 displayed repressed transcription in both cell populations (P < 0.05) (Figure 6C and 6D).
###end p 42
###begin title 43
Discussion
###end title 43
###begin p 44
###xml 164 165 164 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 166 167 166 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 401 407 401 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 411 417 411 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 453 459 453 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 463 469 463 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 607 609 607 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 610 612 610 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 625 631 625 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 635 641 635 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 800 802 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 919 921 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1056 1058 1056 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1059 1061 1059 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1119 1125 1119 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 599 605 <span type="species:ncbi:9913">cattle</span>
###xml 1139 1145 <span type="species:ncbi:9913">bovine</span>
Cell to cell interactions are crucial to the development of the placenta and the exchange of stage-specific molecular signals between the fetal and maternal units [5,6,17,18]. Specifically, these interactions are paramount to programmed fetal growth, maternal adaptation to pregnancy, and coordination of parturition. Trophoblast-specific BNC is a source of an array of biochemical products including bCSH1 and bPRP1 [17,18]. The expression profiles of bCSH1 and bPRP1 are dynamically distinct during gestation, which suggests an intrinsic regulatory role in placental formation and fetal growth in cattle [17-19]. Although, bCSH1 and bPRP1 stem from the same BNC, the mechanism by which endogenous mediators regulate the transcription and translation of these transcripts remains to be established [17]. The stage-specific differential gene expression may be directly or indirectly regulated by transcription factors [26]; however, recent studies have established that epigenetic regulation, particularly DNA methylation, is an important mode of control [27-34]. Here, we show evidence of epigenetic regulation of the bCSH1 transcript in bovine trophoblasts.
###end p 44
###begin p 45
###xml 82 88 82 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 148 153 148 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1</italic>
###xml 177 183 177 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 434 440 434 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 979 981 979 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1006 1012 1006 1012 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 1227 1229 1227 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1458 1464 1458 1464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 1468 1474 1468 1474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 1555 1561 1555 1561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 1565 1571 1565 1571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 13 19 <span type="species:ncbi:9913">bovine</span>
###xml 1674 1680 <span type="species:ncbi:9913">bovine</span>
Treatment of bovine fibroblasts with 5-aza-dC induced an increase in the level of bCSH1 expression in parallel with a decrease in the expression of bPRP1. Ectopic expression of bCSH1 in endometrial fibroblasts and subsequent sequence analysis following 5-aza-dC supplementation provided proof of the concept as well as the practicality of the technique, as has been described for other genes [27-34]. Interestingly, the expression of bCSH1 was restricted to BNC and could not be induced in fibroblasts, including COT fibroblasts (data not shown), implying that the source of the cells as well as the cell microenvironment influences mRNA expression. Additionally, the impact of the length and position of methylation zones may be unique for each gene, and the influence of 5-aza-dC may be quenched depending on the cell/gene milieu. In contrast, compelling evidence obtained over the past decade has demonstrated that histone acetylation is linked to transcriptional activation [30]. Studies involving the Nanog gene, which is a key factor in maintaining the pluripotency of stem cells, revealed that its expression is not affected by 5-aza-dC; however, a combination treatment including trichostatin A facilitated expression [30]. This indicates that gene transcription is intricately regulated by a functional link between DNA methylation and histone acetylation. In this study, we did not examine the biological role of histone acetylation in relation to bCSH1 and bPRP1 regulation, and this remains to be clarified. Although the precise regulation of bCSH1 and bPRP1 remains obscure, our study provides the first evidence of a methylation-based regulatory mechanism for bovine PL-related transcripts.
###end p 45
###begin p 46
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 142 148 142 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 275 281 275 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 516 522 516 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 547 552 547 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1</italic>
###xml 693 698 693 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1</italic>
###xml 1227 1233 1227 1233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 1319 1321 1319 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 1573 1574 1573 1574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1742 1744 1742 1744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
We envisioned that a number of CpG islands in the 5'-flanking region of bCSH1 will be hypomethylated in the COT, taking into account that the bCSH1 gene is a trophoblast-specific transcript [17]. On the other hand, we predicted that the majority of CpG sites associated with bCSH1 in somatic cells, such as SKIN will likely be hypermethylated. The bisulfite sequencing confirmed the above notion, particularly, the results from the day 150 samples (Figure 2B). We further demonstrated that the methylation status of bPRP1 is distinct from that of bCSH1. Generally, the methylation pattern of both genes mirrored their expression profiles throughout gestation, particularly at the -197 site of bPRP1. However, it remains to be elucidated whether the changes observed in the methylation levels of both genes are to some extent dependant on the proportion of somatic versus trophoblast cells in placentomes throughout the various stages of gestation. Hence, it is important to delineate the stage-specific regulatory role of methylation patterns in relation to cell populations to facilitate interpretations of the activation/suppression of trophoblast-specific transcripts. On the other hand, we only detected three CpG sites of bPRP1 that were significantly different between the COT and SKIN samples at day 150 (Figure 3B). The biological significance of the variation in the methylation levels observed between the fibroblast cells and SKIN at day 150 is not clear. However, these differences could be attributable to their divergent expression patterns during gestation [5]. Additionally, the evidence from in-vitro cultures of HeLa cells indicates that the DNA methylation pattern undulates during the cell cycle of a mature somatic cell [35]. Therefore, the likelihood of some dynamic alterations in global methylation levels with progressive subcultures of fibroblasts needs verification.
###end p 46
###begin p 47
###xml 18 24 18 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 99 105 99 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 392 398 392 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 485 491 485 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 563 569 563 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 702 708 702 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 1050 1052 1050 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1053 1055 1053 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1056 1058 1056 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1059 1061 1059 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1465 1470 1465 1470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CSH1 </italic>
###xml 1537 1543 1537 1543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 1642 1648 1642 1648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">oCSH1 </italic>
###xml 1649 1650 1649 1650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1651 1653 1651 1653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1654 1656 1654 1656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1985 1987 1985 1987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1988 1990 1988 1990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1991 1993 1991 1993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1994 1996 1994 1996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1997 1999 1997 1999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 2093 2098 2093 2098 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1</italic>
###xml 2202 2208 2202 2208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 2209 2211 2209 2211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 2231 2233 2231 2233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 2584 2586 2584 2586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 2773 2778 2773 2778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1</italic>
###xml 2904 2909 2904 2909 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1</italic>
###xml 3035 3041 3035 3041 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 3169 3174 3169 3174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1</italic>
###xml 436 442 <span type="species:ncbi:9913">bovine</span>
###xml 1445 1451 <span type="species:ncbi:9913">bovine</span>
###xml 2168 2174 <span type="species:ncbi:9913">bovine</span>
During gestation, bCSH1 expression continuously increases with the progression of gestation, while bPRP1 also increases up to mid-gestation followed by a steady decline [19,20]. The question is what controls this disparate pattern of expression of these co-expressed molecules. Accordingly, we first confirmed the transcriptional activities of both genes and detected no marked difference in bCSH1 activation between the BT-1 cells and bovine fibroblast cells. Similarly, unmethylated bPRP1 constructs retained activity in both cell lines. Notably, the levels of bPRP1 transcriptional activity for the individual constructs were different between the fibroblasts and BT-1 cells. Also, the unmethylated bPRP1 constructs had lower transcriptional activity, while the methylated constructs augmented suppression. Although these results indicate that the expression of both genes is affected by their methylation status, other factors may be participating in their regulation, such as, histone acetylation or ubiquitination and/or transcription factors [27,30,36,37]. In this study, the efficiency of the transfection constructs in BT-1 cells was lower than that in the fibroblast cells (data not shown). So the efficiency of transfection may be affected by the intensity of luciferase activity, and more effective transfection methods need to be developed for precise analysis of luciferase activity. The DNA sequences of the 5'-flanking region in bovine and ovine (o)CSH1 are highly conserved, and the binding site of AP-2 was detected in bCSH1 as a consensus cis-element that is similar to the cis-element (-58 bp) that has been recognized in oCSH1 [3,25,38]. Furthermore, Sp1 (-220 to -215) and GATA (-475 to -470, and -105 to -99) consensus binding sites exist within the -599 region, which was confirmed by GENETYX Ver.8 (Genetyx, Tokyo, Japan). These binding sites might interact with AP-2, as these transcriptional factors are documented to regulate some placental specific genes [24-26,28,39-41]. To date, there are no reports concerning the interplay between transcriptional factors and bPRP1, but AP-2 may be a regulatory factor since its expression profile in bovine placenta parallels that of bPRP1 [26]. Ushizawa et al. [26] reported two AP-2 consensus binding sites in the upstream region within -200 (-44 to -33 and -74 to -63), but surprisingly in this study, the constructs containing these two sites showed no transcriptional activity in either the BT-1 or fibroblast cells. Therefore, the role of the above sites in transcription regulation needs further elucidation [26]. In the present study, we detected a new AP-2 consensus binding site (-267 to -260) using GENETYX Ver.8, and the constructs containing these sites, -860, -510, and -277, exhibited high bPRP1transcriptional activity in BT-1 cells. Therefore, it is plausible that AP-2 is involved in the transcriptional regulation of bPRP1. Additionally, Sp1 (-270 to -265) and GATA (-84 to -79) consensus binding sites were also detected in the upstream region of bPRP1 by GENETYX Ver.8 analysis. This likely denotes combinatorial regulation of the transcriptional activation and/or suppression of bPRP1.
###end p 47
###begin p 48
###xml 310 316 310 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 188 194 <span type="species:ncbi:9913">bovine</span>
In summary, our findings demonstrate that DNA methylation may regulate dynamic changes in gene expression during BNC morphogenesis, placental formation, and trophoblast differentiation in bovine species. However, further studies are necessary to understand the precise transcriptional regulatory mechanisms of bCSH1 and bPRP to comprehend their role in placentogenesis, fetogenesis, maternal recognition and adjustment to pregnancy, and coordination of parturition. This may also provide an insight into the roles of the various homologous and orthologous members of the GH/PRL family that are detected in the placenta.
###end p 48
###begin title 49
Conclusion
###end title 49
###begin p 50
###xml 93 99 93 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 103 109 103 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 137 143 137 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSHI </italic>
###xml 307 313 307 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 317 323 317 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 453 459 <span type="species:ncbi:9913">bovine</span>
Our data indicates for the first time that there are different regulatory mechanisms for the bCSH1 and bPRP1 genes and demonstrates that bCSHI may be subject to transcriptional regulation by DNA methylation. These data unravel the novel kinetics of the induction of the synchronously expressed BNC-specific bCSH1 and bPRP1 transcripts, which may aid the understanding of the intricate regulation and the specific role(s) of these important molecules in bovine placentogenesis and the progression of pregnancy.
###end p 50
###begin title 51
Methods
###end title 51
###begin title 52
Animals and tissue collection
###end title 52
###begin p 53
###xml 398 403 398 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1</italic>
###xml 512 517 512 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1</italic>
###xml 92 96 <span type="species:ncbi:9913">cows</span>
###xml 314 318 <span type="species:ncbi:9913">cows</span>
Placental cotyledonary villi (COT) and fetal skin (SKIN) were collected from Japanese black cows. The artificial insemination day was designated as day 0 of gestation. The tissues collected across specific stages of gestation were designated as follows: (i) Day 60: COT samples were collected from three different cows on days 54, 64, and 65 of gestation (n = 3 animals for bisulfite sequencing of bPRP1); (ii) Day 90: COT samples were collected on days 87, 88, and 97 (n = 3 animals for bisulfite sequencing of bCSH1); (iii) Day 150: COT samples were collected on days 144 (n = 2 animals) and 150 (n = 3 animals for bisulfite sequencing), and SKIN samples were collected from both animals (n = 2 animals for bisulfite sequencing) and designated as Day 150 SKIN; and (iv) Day 250: COT samples were collected on days 245, 249, and 252 (n = 3 animals for bisulfite sequencing). The collected samples were stored at -80degreesC prior to DNA extraction. All procedures for these animal experiments were carried out in accordance with guidelines approved by the Animal Committee of Iwate University and the National Institute of Agrobiological Sciences for the use of animals.
###end p 53
###begin title 54
Cell culture
###end title 54
###begin p 55
###xml 50 52 50 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 115 117 115 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 430 431 423 424 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1017 1019 1010 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1209 1210 1195 1196 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 346 352 <span type="species:ncbi:9913">bovine</span>
###xml 859 865 <span type="species:ncbi:9913">Bovine</span>
###xml 971 977 <span type="species:ncbi:9913">cattle</span>
BT-1 cells established from in vitro blastocysts [42,43] were cultured according to a previously described method [44]. Briefly, the cells were cultured in Dulbecco's modified Eagle's medium/F-12 medium (DMEM/F-12, Sigma, Saint Louis, MI, USA) containing 100 IU/ml of penicillin and 100 mug/ml of streptomycin (Sigma) supplemented with 10% fetal bovine serum (FBS, HANA-NESCO, Tokyo, Japan) at 37degreesC in an atmosphere of 5% CO2. The medium was changed every two or three days. A monolayer of confluent BT-1 cells was mechanically passaged by pipetting. The dissociated cell clumps in the medium were plated on collagen-coated flasks. The cell clumps attached themselves to the flasks and proliferated to re-form a monolayer. Successful passages were also achieved by transferring multicellular vesicles that had spontaneously formed from the cell colony. Bovine endometrial or cotyledonary fibroblast cells, which had been derived from the uteruses of Japanese black cattle and established as detailed elsewhere [45], were cultured in DMEM/F-12 (sigma) containing 100 IU/ml of penicillin and 100 mug/ml of streptomycin (Sigma) supplemented with 10% FBS (HANA-NESCO) at 37degreesC in an atmosphere of 5% CO2. In this study, 4th passaged endometrial fibroblast cells or 9th passaged cotyledonary fibroblast cells were used. The medium was changed every two to three days. A monolayer of confluent fibroblast cells was passaged and scaled down using 0.25% Trypsin-EDTA (Sigma) and plated on flasks.
###end p 55
###begin title 56
5-aza-2'-deoxycytidine treatment
###end title 56
###begin p 57
###xml 26 32 <span type="species:ncbi:9913">bovine</span>
A confluence of 30-40% of bovine endometrial fibroblast cells or cotyledonary fibroblast cells was plated on a 100-mm dish and incubated for 24 h. Then, the cells were treated with either vehicle or 10 muM 5-aza-2'-deoxycytidine (5-aza-dC) in an FBS-containing medium for 72 h. The medium and 5-aza-dC were changed every 24 h. The BT-1 cells were treated as described above.
###end p 57
###begin p 58
Total RNA was isolated from the cultured cells using TRIzol Reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. The RNA concentration was calculated by measuring the absorbance with a spectrophotometer (U-2000A, HITACHI, Tokyo, Japan). All RNA samples were stored at -80degreesC prior to processing.
###end p 58
###begin title 59
RT-PCR
###end title 59
###begin p 60
###xml 470 475 464 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1</italic>
###xml 477 482 471 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1</italic>
###xml 488 494 482 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH </italic>
###xml 514 515 508 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 563 565 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
One microgram of total RNA was reverse transcribed into cDNA with a Random Primer (TOYOBO, Osaka, Japan) and Superscript III reverse transcriptase (Invitrogen). PCR was performed using AmpliTaq Gold DNA polymerase (Applied Biosystems, Foster City, CA, USA). The annealing temperature was 60degreesC, and the PCR involved 35 cycles. The PCR products were analyzed by agarose gel electrophoresis and visualized by ethidium bromide staining. The respective primer sets for bCSH1, bPRP1, and GAPDH are listed in Table 1. All the primers were designed using Primer 3 [46] and commercially synthesized (Greiner, Tokyo, Japan). The PCR products were extracted from agarose gel and purified using a GENECLEAN III Kit (MP Biomedicals, Solon, OH, USA). The purified PCR products were ligated to the pGEM-T Easy vector (Promega, Madison, WI, USA) and amplified in DH-5alpha (Invitrogen). All plasmids were purified using the QIAprep Spin Miniprep Kit (QIAGEN, Valencia, CA, USA) and sequenced using an ABI Prism 3100 automatic sequencer (Applied Biosystems).
###end p 60
###begin p 61
The Oligonucleotide primers used for the RT-PCR and quantitative real-time RT-PCR.
###end p 61
###begin title 62
Quantitative real-time RT-PCR
###end title 62
###begin p 63
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 420 421 420 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 846 852 822 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH </italic>
Real-time RT-PCR was performed using the SYBR Green Detection System (Applied Biosystems) according to the method described previously [26]. PCR and the resulting increase in reporter fluorescent dye emission were monitored in real time using a 7300 Real Time PCR System (Applied Biosystems). The primer pair was designed by the Primer Express Program (Applied Biosystems). The primers for each gene are listed in Table 1. The thermal cycling conditions included one cycle at 50degreesC for 2 min, one cycle at 95degreesC for 10 min, and 40 cycles at 95degreesC for 15 s and 60degreesC for 1 min. To quantify the mRNA concentrations, standard curves were generated for each gene by serial dilution of the plasmids containing their cDNA. The expression ratio of each gene was normalized relative to the abundance of a validated endogenous control GAPDH mRNA to adjust for variations in the RT-PCR reaction. Quantitation was performed using three separately cultured samples per condition, and all values are presented as mean +/- SEM.
###end p 63
###begin title 64
Genomic DNA extraction
###end title 64
###begin p 65
The genomic DNA was extracted from COT, SKIN, and cultured cells using a Puregene DNA Purification System (Gentra Systems, Minnesota, U.S.A.) according to the manufacturer's instructions. The DNA concentration was calculated by a spectrophotometer. All DNA samples were stored at -30degreesC prior to processing.
###end p 65
###begin title 66
Preparing constructs for sequencing and luciferase reporter assays
###end title 66
###begin p 67
###xml 43 49 43 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 111 117 111 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
###xml 121 127 121 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 338 339 338 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 344 345 344 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 943 945 937 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
The sequence of the 5'-flanking regions of bCSH1 and bPRP1 was confirmed by cloning them. Each fragment of the bCSH1 and bPRP1 regions was amplified using PCR with primers designed on Map Viewer, which is available on the NCBI web site [47]. Each PCR was performed using KOD-Plus-Ver.2 (TOYOBO). The primer sets used are listed in Tables 2 and 3. The annealing temperature was set at 62 to 65.5degreesC, and the PCR lasted 30 cycles. The PCR products were analyzed by agarose gel electrophoresis and visualized by ethidium bromide staining. The PCR products were cut by Kpn I (TOYOBO) and Xho I (TOYOBO), or Sac I (TOYOBO) and Xho I, before being cloned into the pGL3-Basic vector (Promega) using a DNA Ligation Kit Ver.2.1 (TaKaRa, Tokyo, Japan). All constructs were amplified in SCS110 (Stratagene, La Jolla, CA, USA), which lacks two methylases (dcm and dam), and sequenced using an ABI Prism 3100 automatic sequencer (Applied Biosystems) [30].
###end p 67
###begin p 68
###xml 25 31 25 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1 </italic>
The primers used for the bCSH1 (NW_001494181) 5'-flanking region of the sequencing and reporter constructs.
###end p 68
###begin p 69
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 141 143 141 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
a All forward primers have a KpnI recognition site (-GGTACC-), and the reverse primer has an XhoI recognition site (-CTCGAG-) at its 5'-end. b The reverse primer is common to all PCRs.
###end p 69
###begin p 70
###xml 25 31 25 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1 </italic>
The primers used for the bPRP1 (AH001153) 5'-flanking region of the sequencing and reporter constructs.
###end p 70
###begin p 71
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 54 56 54 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
###xml 109 111 109 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c </sup>
a The primers have a SacI recognition site (-GAGCTC-).b The primers have a KpnI recognition site (-GGTACC-). c The common reverse primers for all forward primers have an XhoI recognition site (-CTCGAG-) at their 5'-end.
###end p 71
###begin title 72
Sodium bisulfite genomic sequencing
###end title 72
###begin p 73
###xml 123 128 123 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1</italic>
###xml 189 194 189 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1</italic>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 402 404 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 453 458 452 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1</italic>
###xml 474 479 473 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1</italic>
###xml 235 241 <span type="species:ncbi:9913">bovine</span>
CpG methylation status was examined at each stage of gestation (Day 90 COT, Day 150 COT, Day 250 COT, and Day 150 SKIN for bCSH1; Day 60 COT, Day 150 COT, Day 250 COT, and Day 150 SKIN for bPRP1) as well as in cultured cells (BT-1 and bovine fibroblast cells) by sodium bisulfite genomic sequencing analysis. The details of the sodium bisulfite genomic sequencing are contained in previous reports [32,33]. Briefly, DNA (1 mug) digested with EcoRI (for bCSH1) or BamHI (for bPRP1) was denatured in 0.3 M NaOH at 37degreesC for 15 min. Then, 3.6 M sodium bisulfite (pH 5.0) and 0.6 mM hydroquinone were added, and the sample underwent 15 cycles of 30 s denaturation at 95degreesC and 15 min of incubation at 50degreesC. The sample was desalted using the Wizard DNA Clean-up system (Promega) and desulfonated in 0.3 M NaOH. DNA was ethanol precipitated and dissolved in 40 mul of Tris-EDTA buffer. All modified DNA samples were stored at -80degreesC prior to processing.
###end p 73
###begin p 74
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 142 143 142 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
The DNA fragments were amplified with bisulfite PCR using AmpliTaq Gold (Applied Biosystems) and the set of primers described in Tables 4 and 5. The primer design was performed using MethPrimer [48]. The annealing temperature was set at 56 to 62degreesC, and the total number of cycles was 35. The PCR products were analyzed by agarose gel electrophoresis and visualized by ethidium bromide staining. The PCR products were cloned into a pGEM-T Easy vector (Promega). Ten clones from COT and 15 clones from SKIN for each sample and region (calculated as total 30 clones per region) were sequenced using an ABI Prism 3100 automatic sequencer (Applied Biosystems), and the methylation ratios of the samples were determined. Thirty clones from cultured cells from each sample and region were sequenced using an ABI Prism 3100 automatic sequencer. All results are shown as percentages.
###end p 74
###begin p 75
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bCSH1</italic>
The primers used for the bisulfite sequencing of bCSH1.
###end p 75
###begin p 76
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bPRP1</italic>
The primers used for the bisulfite sequencing of bPRP1.
###end p 76
###begin title 77
In vitro methylation of constructs
###end title 77
###begin p 78
###xml 65 74 65 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 192 194 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 300 302 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
The constructs for the luciferase reporter assay were methylated in vitro by SssI CpG methylase (New England BioLabs) in the presence of 160 muM of S-adenosylmethionine at 37degreesC for 3 h [30]. Completion of the methylation reaction was confirmed when digestion with Hha I was no longer possible [49].
###end p 78
###begin title 79
Luciferase reporter assay
###end title 79
###begin p 80
###xml 96 105 96 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 645 647 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 156 162 <span type="species:ncbi:9913">bovine</span>
###xml 408 414 <span type="species:ncbi:9913">Bovine</span>
The constructed plasmids with or without methylation were transfected into BT-1 using ExGen 500 in vitro Transfection Reagent (Fermentas, Hanover, USA) and bovine fibroblast cells using FuGENE 6 (Roche Diagnostics, Basel, Switzerland). After 10 days of passaging, the BT-1 cells were transfected with 5 mug of constructs and 50 ng of pRL-TK (Promega), and cultured in the conditions detailed above for 72 h. Bovine fibroblast cells were transfected with 200 ng of constructs and 2 ng of pRL-TK and cultured in the conditions described above for 48 h. The luciferase activity was measured by a TR-717 Microplate Luminometer (Applied Biosystems) [50]. The activity of all constructs was determined using a Dual-Luciferase Reporter Assay System (Promega) according to the manufacturer's instructions. Assays were performed three times, and all results are shown as the mean +/- SEM.
###end p 80
###begin title 81
Statistic analysis
###end title 81
###begin p 82
The Student's t-test and Pearson's chi-square test were used to analyze the statistical differences between the 5-aza-dC supplemented and non-supplemented samples and the sodium bisulfite treated genomic sequences, respectively. Differences among luciferase reporter constructs were assessed by one-way ANOVA, followed by the Tukey-Kramer multiple comparison test. Differences were considered significant at P < 0.05.
###end p 82
###begin title 83
Authors' contributions
###end title 83
###begin p 84
YN participated in the design of the study, carried out most of the experiments, and wrote the manuscript. KK participated in coordinating the design of the study. TT supplied the tissue samples. OVP participated in the discussion and provided insights into the manuscript. KH planned and participated in coordinating the design of the study, contributed to drafting the manuscript, and supervised the process. All authors have read and approved the final manuscript.
###end p 84
###begin title 85
Acknowledgements
###end title 85
###begin p 86
We thank Kumiko Sugawara for her technical assistance. This study was supported by a Research Project for Utilizing Advanced Technologies (05-1770) grant from the Ministry of Agriculture, Forestry, and Fisheries of Japan; a grant (Kiban-kenkyu B 17380172) from the Ministry of Education, Culture, Sport, Science, and Technology of Japan; and a grant from the Animal Remodeling Project (05-201, 202) of the National Institute of Agrobiological Sciences.
###end p 86
###begin article-title 87
###xml 0 6 <span type="species:ncbi:9913">Bovine</span>
Bovine placental lactogen: molecular cloning and protein structure
###end article-title 87
###begin article-title 88
###xml 59 65 <span type="species:ncbi:9913">bovine</span>
Molecular cloning of a prolactin-related mRNA expressed in bovine placenta
###end article-title 88
###begin article-title 89
###xml 17 23 <span type="species:ncbi:9913">bovine</span>
Structure of the bovine placental lactogen gene and alternative splicing of transcripts
###end article-title 89
###begin article-title 90
###xml 35 41 <span type="species:ncbi:9913">bovine</span>
Nomenclature clarification for the bovine placental prolactin-related hormones
###end article-title 90
###begin article-title 91
###xml 71 77 <span type="species:ncbi:9913">bovine</span>
###xml 88 94 <span type="species:ncbi:9913">bovine</span>
Cloning and expression of a new member of prolactin-related protein in bovine placenta: bovine prolactin-related protein-VII
###end article-title 91
###begin article-title 92
###xml 105 111 <span type="species:ncbi:9913">bovine</span>
Cloning and expression of two new prolactin-related proteins, prolactin-related protein-VIII and -IX, in bovine placenta
###end article-title 92
###begin article-title 93
###xml 57 63 <span type="species:ncbi:9913">cattle</span>
Discovery of eight novel divergent homologs expressed in cattle placenta
###end article-title 93
###begin article-title 94
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
Molecular cloning and expression of mouse placental lactogen I complementary deoxyribonucleic acid
###end article-title 94
###begin article-title 95
###xml 21 26 <span type="species:ncbi:10090">mouse</span>
Molecular cloning of mouse placental lactogen cDNA
###end article-title 95
###begin article-title 96
###xml 36 39 <span type="species:ncbi:10116">rat</span>
Molecular cloning and expression of rat placental lactogen-I complementary deoxyribonucleic acid
###end article-title 96
###begin article-title 97
###xml 91 95 <span type="species:ncbi:9925">goat</span>
Purification, partial characterization, and development of a specific radioimmunoassay for goat placental lactogen
###end article-title 97
###begin article-title 98
Roles of prolactin and related members of the prolactin/growth hormone/placental lactogen family in angiogenesis
###end article-title 98
###begin article-title 99
Ruminant placental lactogens: structure and biology
###end article-title 99
###begin article-title 100
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
The mouse prolactin gene family locus
###end article-title 100
###begin article-title 101
###xml 90 96 <span type="species:ncbi:9913">bovine</span>
Gene expression profiles of novel caprine placental prolactin-related proteins similar to bovine placental prolactin-related proteins
###end article-title 101
###begin article-title 102
###xml 60 66 <span type="species:ncbi:9913">bovine</span>
Expression and characterization of novel ovine orthologs of bovine placental prolactin-related proteins
###end article-title 102
###begin article-title 103
###xml 106 110 <span type="species:ncbi:9913">cows</span>
Expression of prolactin-related protein 1 at the fetomaternal interface during the implantation period in cows
###end article-title 103
###begin article-title 104
Trophoblast cells of ruminant placentas - A minireview
###end article-title 104
###begin article-title 105
###xml 93 99 <span type="species:ncbi:9913">bovine</span>
Temporospatial expression of placental lactogen and prolactin-related protein-1 genes in the bovine placenta and uterus during pregnancy
###end article-title 105
###begin article-title 106
###xml 48 54 <span type="species:ncbi:9913">bovine</span>
Gene expression and maintenance of pregnancy in bovine: roles of trophoblastic binucleate cell-specific molecules
###end article-title 106
###begin article-title 107
###xml 70 75 <span type="species:ncbi:9606">human</span>
Sp1 and tyroid hormone receptor differentially activate expression of human growth hormone and chorionic somatomammotropin genes
###end article-title 107
###begin article-title 108
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
Trophoblast-specific transcription from the mouse placental lactogen-I gene promoter
###end article-title 108
###begin article-title 109
###xml 96 101 <span type="species:ncbi:10090">mouse</span>
GATA factor activity is required for the trophoblast-specific transcriptional regulation of the mouse placental lactogen I gene
###end article-title 109
###begin article-title 110
###xml 55 58 <span type="species:ncbi:10116">rat</span>
Identification of a placental-specific enhancer in the rat placental lactogen II gene that contains binding sites for members of the Ets and AP-1 (activator protein1) families of transcription factors
###end article-title 110
###begin article-title 111
Structure and transcriptional regulation of the ovine placental lactogen gene
###end article-title 111
###begin article-title 112
###xml 83 89 <span type="species:ncbi:9913">bovine</span>
Global gene expression analysis and regulation of the principal genes expressed in bovine placenta in relation to the transcription factor AP-2 family
###end article-title 112
###begin article-title 113
###xml 22 27 <span type="species:ncbi:10090">mouse</span>
Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells and trophoblast stem cells
###end article-title 113
###begin article-title 114
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
DNA methylation-mediated control of Sry gene expression in mouse gonadal development
###end article-title 114
###begin article-title 115
DNA methylation-dependent epigenetic regulation of dimethylarginine dimethylaminohydrolase 2 gene in trophoblast cell lineage
###end article-title 115
###begin article-title 116
Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells
###end article-title 116
###begin article-title 117
Increase in DNA methylation downregulates conceptus interferon-tau gene expression
###end article-title 117
###begin article-title 118
###xml 104 109 <span type="species:ncbi:9606">human</span>
Silencing of peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas
###end article-title 118
###begin article-title 119
Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2'-deoxycytidine treatment and oligonucleotide microarray
###end article-title 119
###begin article-title 120
DNA methylation regulates placental lactogen I gene expression
###end article-title 120
###begin article-title 121
Variation in DNA methylation patterns during the cell cycle of HeLa cells
###end article-title 121
###begin article-title 122
Epigenetic control of fetal gene expression
###end article-title 122
###begin article-title 123
Epigenetic landscape required for placental development
###end article-title 123
###begin article-title 124
Novel activator protein-2alpha splice-variants function as transactivators of the ovine placental lactogen gene
###end article-title 124
###begin article-title 125
###xml 36 41 <span type="species:ncbi:9606">human</span>
A placenta-specific enhancer of the human syncytin gene
###end article-title 125
###begin article-title 126
A retroviral promoter and a cellular enhancer define a bipartite element which controls env ERWE1 placental expression
###end article-title 126
###begin article-title 127
###xml 64 69 <span type="species:ncbi:9606">human</span>
GATA-4 and GATA-6 modulate tissue-specific transcription of the human gene for P450c17 by direct interaction with Sp1
###end article-title 127
###begin article-title 128
###xml 36 42 <span type="species:ncbi:9913">bovine</span>
Isolation and characterization of a bovine blastocysts-derived trophoblastic cell line, BT-1: development of a culture system in the absence of feeder cell
###end article-title 128
###begin article-title 129
###xml 0 6 <span type="species:ncbi:9913">Bovine</span>
Bovine trophoblastic cell differentiation on collagen substrata: formation of binucleate cells expressing placental lactogen
###end article-title 129
###begin article-title 130
###xml 0 6 <span type="species:ncbi:9913">Bovine</span>
###xml 64 70 <span type="species:ncbi:9913">bovine</span>
Bovine trophoblast cell culture systems: A technique to culture bovine trophoblast cells without feeder cells
###end article-title 130
###begin article-title 131
###xml 112 118 <span type="species:ncbi:9913">bovine</span>
Proliferative potential of endometrial stromal cells, and endometrial and placental expression of cyclin in the bovine
###end article-title 131
###begin article-title 132
Primer3
###end article-title 132
###begin article-title 133
NCBI website
###end article-title 133
###begin article-title 134
MethPrimer
###end article-title 134
###begin article-title 135
###xml 120 125 <span type="species:ncbi:10090">mouse</span>
Tissue-specific characterisation of DNA methylation in the gonad-specific proto-oncogene, c-mos, in the male laboratory mouse
###end article-title 135
###begin article-title 136
###xml 34 39 <span type="species:ncbi:9606">human</span>
Transcriptional regulation of the human UDP-galactose: ceramide galactosyltransferase (hCGT) gene expression: functional role of GC-box and CRE
###end article-title 136

